Ondansetron
Product Images NDC 68071-2909

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68071-2909). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2909 1)

Pdp (68071 2909 1)
Label for Ondansetron ODT 8 mg tablets by NuCare Pharmaceuticals, Inc. The package contains 10 orally disintegrating tablets. It states each tablet contains 8 mg Ondansetron USP and 3.37 mg phenylalanine. The label includes storage instructions, manufacturer information, and regulatory warnings. Several NDC numbers and lot/serial details are present.*
FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical Structure (Ondansetronod Str)
Chemical structure diagram of Ondansetron, illustrating the arrangement of its atoms and bonds in a skeletal formula format.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.